Cargando…
RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies
The treatment landscape of prostate cancer has evolved rapidly over the past five years. The explosion in treatment advances has been witnessed in parallel with significant progress in the field of molecular biomarkers. The advent of next-generation sequencing has enabled the molecular profiling of...
Autores principales: | Lim, Marvin C. J., Baird, Anne-Marie, Aird, John, Greene, John, Kapoor, Dhruv, Gray, Steven G., McDermott, Ray, Finn, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163368/ https://www.ncbi.nlm.nih.gov/pubmed/30200254 http://dx.doi.org/10.3390/diagnostics8030060 |
Ejemplares similares
-
Carcinogenesis in prostate cancer: The role of long non-coding RNAs
por: Aird, John, et al.
Publicado: (2018) -
Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide
por: Greene, John, et al.
Publicado: (2019) -
Circular RNAs: Biogenesis, Function and Role in Human Diseases
por: Greene, John, et al.
Publicado: (2017) -
hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro
por: Lim, Marvin C. J., et al.
Publicado: (2021) -
Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer
por: Greene, John, et al.
Publicado: (2021)